Evidence map›Paper›PMID 38620646›Full record

ReviewOpen respiratory archives

Use of Conventional Chest Imaging and Artificial Intelligence in COVID-19 Infection. A Review of the Literature.

María Dolores Corbacho Abelaira, Fernando Corbacho Abelaira, Alberto Ruano-Ravina, Alberto Fernández-Villar

Abstract readReview
In one paragraph

Review in Open respiratory archives. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Deep CNN models for predicting COVID-19 in CT and x-ray images.Journal of medical imaging (Bellingham, Wash.) · 2021
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

María Dolores Corbacho AbelairaPulmonary Department, Hospital POVISA, Vigo, Spain.
Fernando Corbacho AbelairaCognodata Consulting, Madrid, Spain.
Alberto Ruano-RavinaMedicine School, University of Santiago, Area of Preventive Medicine and Public Health, CIBER of Epidemiology and Public Health, CIBERESP, Instituto de Salud Carlos II, Spain.
Alberto Fernández-VillarPulmonary Department, Hospital Álvaro Cunqueiro, EOXI Vigo, PneumoVigoI+I Research Group, Health Research Institute Galicia Sur (IIS Galicia Sur), Vigo, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coronavirus disease caused by SARS-Cov-2 is a pandemic with millions of confirmed cases around the world and a high death toll. Currently, the real-time polymerase chain reaction (RT-PCR) is the standard diagnostic method for determining COVID-19 infection. Various failures in the detection of the disease by means of laboratory samples have raised certain doubts about the characterisation of the infection and the spread of contacts. In clinical practice, chest radiography (RT) and chest computed tomography (CT) are extremely helpful and have been widely used in the detection and diagnosis of COVID-19. RT is the most common and widely available diagnostic imaging technique, however, its reading by less qualified personnel, in many cases with work overload, causes a high number of errors to be committed. Chest CT can be used for triage, diagnosis, assessment of severity, progression, and response to treatment. Currently, artificial intelligence (AI) algorithms have shown promise in image classification, showing that they can reduce diagnostic errors by at least matching the diagnostic performance of radiologists. This review shows how AI applied to thoracic radiology speeds up and improves diagnosis, allowing to optimise the workflow of radiologists. It can provide an objective evaluation and achieve a reduction in subjectivity and variability. AI can also help to optimise the resources and increase the efficiency in the management of COVID-19 infection.

Indexed as

Artificial intelligenceChest X-rayComputed tomographyCovid-19Deep learning

Identifiers

PMID38620646
PMCPMC7834680

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.